Overview

Observational Study Describing Conditions for Intensification of Insulin Therapy in Type 2 Diabetes

Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
0
Participant gender:
All
Summary
This study is conducted in Europe. The aim of this observational study is to determine diabetes control improvement, during the third month of follow-up after insulin intensification to at least 3 daily insulin injections, in assessing the proportion of uncontrolled fasting and postprandial glycaemia values recorded on a diary.
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Insulin
Insulin, Globin Zinc
Criteria
Inclusion Criteria:

- Type 2 diabetes patients

- Treatment with two insulin daily injections and needing insulin intensification
regimen to at least three daily injections

- HbA1c greater than or equal to 8.0%

Exclusion Criteria:

- Patients not performing glycaemia self-measurements

- Secondary diabetes

- Requirement of or use of an insulin pump

- Treatment with corticoids